Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies
Authors
Keywords
-
Journal
Future Oncology
Volume 17, Issue 27, Pages 3549-3560
Publisher
Future Medicine Ltd
Online
2021-06-22
DOI
10.2217/fon-2021-0576
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
- (2021) Takahiro Miyazaki et al. Journal for ImmunoTherapy of Cancer
- IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion
- (2019) Kevin C Conlon et al. CLINICAL CANCER RESEARCH
- Prognostic impact of natural killer cell count in follicular lymphoma and diffuse large B-cell lymphoma patients treated with immunochemotherapy
- (2019) Magdalena Klanova et al. CLINICAL CANCER RESEARCH
- Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
- (2019) Joseph Mikhael et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- NK Cells in the Treatment of Hematological Malignancies
- (2019) Gonzalez-Rodriguez et al. Journal of Clinical Medicine
- Combination of NKTR-255, a Polymer Conjugated Human IL-15, with CD19 CAR T Cell Immunotherapy in a Preclinical Lymphoma Model
- (2019) Cassie Chou et al. BLOOD
- One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy
- (2018) Laurie Besson et al. Frontiers in Immunology
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The potential and promise of IL-15 in immuno-oncogenic therapies
- (2017) Tanya O. Robinson et al. IMMUNOLOGY LETTERS
- Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
- (2017) Gianfranco Pittari et al. Frontiers in Immunology
- Multiple myeloma in the marrow: pathogenesis and treatments
- (2016) Heather Fairfield et al. Annals of the New York Academy of Sciences
- CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma
- (2016) Inger S. Nijhof et al. BLOOD
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
- (2012) Laure Farnault et al. Clinical & Developmental Immunology
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates
- (2010) E. Lugli et al. BLOOD
- Activity of Recombinant Human Interleukin-15 against Tumor Recurrence and Metastasis in Mice
- (2010) Feng Tang et al. Cellular & Molecular Immunology
- Natural killer cell activity in monoclonal gammopathies: Relation to disease activity
- (2010) A. Österborg et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Twelve immunotherapy drugs that could cure cancers
- (2008) Martin A. ‘Mac’ Cheever IMMUNOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started